Robert Michael Dudley, CEO: Transcode Therapeutics RNAZ Buy · Filed 23/06/22

Trade details

Type: Insider buy
Amount: $16,847.85
Shares · price: 6,607 sh · $2.55 a share
Held after: 70,262 sh
Stock: Transcode Therapeutics RNAZ
Person: Robert Michael DudleyCEO
Trade date: 23/06/20
Filed: 23/06/22
Days to filing: 2 days

Holdings up 10.4%

Insiders buying this week: 1 insiders
Holding change: +10.4%

Transcode Therapeutics trades, last 26 weeks

What else happened in Transcode Therapeutics around then

Filed or reported within 30 days of the trade day · 23/05/21~23/07/20

Robert Michael Dudley's recent trades

Robert Michael DudleyCEO
BuyTranscode Therapeutics
Buy
Transcode Therapeutics
RNAZ
$50K
98,000 sh
$50K
Filed 23/10/02
Traded 23/09/28
Robert Michael DudleyCEO
BuyTranscode Therapeutics
Buy
Transcode Therapeutics
RNAZ
$31.8K
12,000 sh
$31.8K
Filed 23/06/22
Traded 23/06/21
Robert Michael DudleyCEO
BuyTranscode Therapeutics
Buy
Transcode Therapeutics
RNAZ
$52.4K
19,000 sh
$52.4K
Filed 23/06/14
Traded 23/06/09
Robert Michael DudleyCEO
BuyTranscode Therapeutics
Buy
Transcode Therapeutics
RNAZ
$52.4K
19,000 sh
$52.4K
Filed 23/06/13
Traded 23/06/09